Isatuximab (Sarclisa)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Isatuximab (Sarclisa), covering 2025-01-16 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]